CUE Cue Biopharma Inc.

Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.

$2.39  +0.16 (7.18%)
As of 10/03/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/02/2018
Outstanding shares:  35,381,743
Average volume:  122,004
Market cap:   $78,901,287
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BD9G8M7
Valuation   (See tab for details)
PE ratio:   -1.84
PB ratio:   1.26
PS ratio:   10.25
Return on equity:   -70.99%
Net income %:   -596.14%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy